At ATCCS 2025 in Hong Kong, Asia’s leading thoracic surgery summit, Surgerii Robotics unveiled its cutting-edge SHURUI® single-port robot, becoming the only Chinese surgical robot brand invited to the event. Designed with proprietary snake-arm technology, the system captured global attention with its flexibility, precision, and ultra-minimally invasive design.
Surgerii Robotics aligns with key ATCCS themes such as uniportal thoracic surgery and intelligent robotics. Its single-incision platform and dexterous instruments offer breakthrough capabilities in confined chest spaces.
International leaders, including Prof. Jens C. Rueckert and Prof. Calvin NG, praised the system’s potential. Over 50 surgeons from Europe and Asia joined Surgerii’s Dry Lab international session for hands-on training, highlighting its role in shaping the future of robotic thoracic surgery.
From concept to clinical readiness, Surgerii Robotics is bridging Chinese innovation with global surgical excellence—truly going “Beyond the Horizon.”
Important Notes
The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other
trademarks and may not be used without permission.
